Effect of Shuangdan Mingmu Capsule on Diabetic Retinopathy in Rats via Regulation of miRNAs

References

• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–186. doi:10.1016/j.preteyeres.2015.08.001
   PubMed Web of Science ®Google Scholar
• Chaoxiu Q, Xuhua T, Qigen L, Xiaoli W. Clinical study of compound Danshen dripping pills in the treatment of diabetic retinopathy. Chine Materia Medica. 2007;3:375–377. doi:10.13863/j.issn1001-4454.2007.03.045
   Google Scholar
• Min Z. Effects of Ginkgo biloba extract tablets on diabetic retinopathy and pharmacological analysis. Chine Med Guide. 2020;18(12):197–198. doi:10.15912/j.cnki.gocm.2020.12.095
   Google Scholar
• Guoqiang G, Wenzhong Y. Clinical study of Yiqi Yangyin Huoxue Tang assisting Conbercept for diabetic retinopathy complicated with vitreous hemorrhage. New Chine Med. 2022;54(3):75–79. doi:10.13457/j.cnki.jncm.2022.03.016
   Google Scholar
• Nie F, Yan J, Ling Y, et al. Effect of Shuangdan Mingmu capsule, a Chinese herbal formula, on oxidative stress-induced apoptosis of pericytes through PARP/GAPDH pathway. BMC Complement Med Ther. 2021;21(1):118. doi:10.1186/s12906-021-03238-w
   Google Scholar
• Chaojun F, Yongwang Z, Yanjun L, et al. Effects of Shuangdan Mingmu Capsule on the expressions of Spred-1 and VEGF in the retina of rats with diabetic retinopathy. China J New Drugs. 2019;28(23):2893–2898. doi:10.3969/j.issn.1003-3734.2019.23.017
   Google Scholar
• Jun P, Kun P, Zheng-Rong L, Yu-Hui Q, Qing-Hua P. Effects of Shuang Dan Ming Mu Capsule on expression of VEGF-a, VEGF-b, VEGF-c and the VEGF receptor, Flk-1, in diabetic retinopathy rats. Digital Chine Med. 2018;1(3):548.
   Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Gong Q, Su G. Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy. Biosci Rep. 2017;37(6):BSR20171157. doi:10.1042/BSR20171157
   PubMed Web of Science ®Google Scholar
• Xiong F, Du X, Hu J, Li T, Du S, Wu Q. Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis. Curr Eye Res. 2014;39(7):720–729. doi:10.3109/02713683.2013.872280
   PubMed Web of Science ®Google Scholar
• Regazzi R. MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications. Expert Opin Ther Targets. 2018;22(2):153–160. doi:10.1080/14728222.2018.1420168
   PubMed Web of Science ®Google Scholar
• Satari M, Aghadavod E, Mirhosseini N, Asemi Z. The effects of microRNAs in activating neovascularization pathways in diabetic retinopathy. J Cell Biochem. 2019;120(6):9514–9521. doi:10.1002/jcb.28227
   PubMed Web of Science ®Google Scholar
• Ye EA, Steinle JJ. miR-146a attenuates inflammatory pathways mediated by TLR4/NF-κB and TNFα to protect primary human retinal microvascular endothelial cells grown in high glucose. Mediators Inflamm. 2016;2016:3958453. doi:10.1155/2016/3958453
   PubMed Web of Science ®Google Scholar
• Li HL, Hao GM, Tang SJ, et al. HuoXue JieDu formula improves diabetic retinopathy in rats by regulating microRNAs. J Ethnopharmacol. 2021;268:113616. doi:10.1016/j.jep.2020.113616
   Web of Science ®Google Scholar
• Deng W, Huang D, Xie H, et al. Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1. Bioengineered. 2022;13(4):8187–8200. doi:10.1080/21655979.2021.2006964
   PubMed Web of Science ®Google Scholar
• Dai C, Jiang S, Chu C, Xin M, Song X, Zhao B. Baicalin protects human retinal pigment epithelial cell lines against high glucose-induced cell injury by up-regulation of microRNA-145. Exp Mol Pathol. 2019;106:123–130. doi:10.1016/j.yexmp.2019.01.002
   PubMed Web of Science ®Google Scholar
• Li L, Li YL, Zhou YF, et al. Jiangtang Xiaozhi Recipe prevents diabetic retinopathy in streptozotocin-induced diabetic rats. Chin J Integr Med. 2017;23(6):425–432. doi:10.1007/s11655-016-2595-x
   Web of Science ®Google Scholar
• Shuyun X, Rulian B, Xiu C. The second edition of ”Pharmacological Experiment Methodology” was published. Chin Pharmacological Bulletin. 1992;1:19.
   Google Scholar
• Hongping L, Yuhui Q, Zhengrong L, Yuhong W, Rong Y. Analysis of chemical constituents of Shuangdan Mingmu capsule by UPLC-Q-TOF. Chine Patent Med. 2017;39(07):1527–1531. doi:10.3969/j.issn.1001-1528.2017.07.046)
   Google Scholar
• Hongping L, Yuhui Q, Zhengrong L, Yuhong W, Rong Y. UPLC-Q-TOF-MS analysis of blood components of Shuangdanmingmu capsule. Chin Proprietary Med. 2017;39(10):2204–2206. doi:10.3969/j.issn.1001-1528.2017.10.049
   Google Scholar
• Gene T. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330–D338. doi:10.1093/nar/gky1055
   Web of Science ®Google Scholar
• Dianwei M, Xuejun X, Jing L, Mei Z. Effects of Bushen Huoxue Recipe on PEDF and VEGF in retinal Müller cells under AGEs/hypoxic conditions. China J Traditional Chine Med Ophthalmol. 2021;31(03):157–163. doi:10.13444/j.cnki.zgzyykzz.2021.03.001
   Google Scholar
• Gao D, Guo Y, Li X, et al. An aqueous extract of Radix Astragali, Angelica sinensis, and Panax notoginseng is effective in preventing diabetic retinopathy. Evid Based Complement Alternat Med. 2013;2013:578165. doi:10.1155/2013/578165
   Web of Science ®Google Scholar
• Gao D, Li Q, Li Y, et al. Antidiabetic and antioxidant effects of oleanolic acid from Ligustrum lucidum Ait in alloxan-induced diabetic rats. Phytother Res. 2009;23(9):1257–1262. doi:10.1002/ptr.2603
   PubMed Web of Science ®Google Scholar
• Lee SI, Oh SH, Park KY, Park BH, Kim JS, Kim SD. Antihyperglycemic effects of fruits of privet (Ligustrum obtusifolium) in streptozotocin-induced diabetic rats fed a high fat diet. J Med Food. 2009;12(1):109–117. doi:10.1089/jmf.2007.0000
   Web of Science ®Google Scholar
• Wu J, Ke X, Fu W, et al. Inhibition of hypoxia-induced retinal angiogenesis by Specnuezhenide, an effective constituent of Ligustrum lucidum Ait., through suppression of the HIF-1α/VEGF signaling pathway. Molecules. 2016;21(12):1756. doi:10.3390/molecules21121756
   Web of Science ®Google Scholar
• Feng L, Zhai YY, Xu J, et al. A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.). L J Ethnopharmacol. 2019;245:112109. doi:10.1016/j.jep.2019.112109
   PubMed Web of Science ®Google Scholar
• Ananthi J, Prakasam A, Pugalendi KV. Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats. Yale J Biol Med. 2003;76(3):97–102.
   Google Scholar
• Jaiswal N, Bhatia V, Srivastava SP, Srivastava AK, Tamrakar AK. Antidiabetic effect of Eclipta alba associated with the inhibition of alpha-glucosidase and aldose reductase. Nat Prod Res. 2012;26(24):2363–2367. doi:10.1080/14786419.2012.662648
   PubMed Web of Science ®Google Scholar
• Yang CY, Wang J, Zhao Y, et al. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components. J Ethnopharmacol. 2010;130(2):231–236. doi:10.1016/j.jep.2010.04.039
   Web of Science ®Google Scholar
• Xu C, Wang W, Wang B, et al. Analytical methods and biological activities of Panax notoginseng saponins: recent trends. J Ethnopharmacol. 2019;236:443–465. doi:10.1016/j.jep.2019.02.035
   PubMed Web of Science ®Google Scholar
• Xie Z, Loi Truong T, Zhang P, Xu F, Xu X, Li P. Dan-Qi prescription ameliorates insulin resistance through overall corrective regulation of glucose and fat metabolism. J Ethnopharmacol. 2015;172:70–79. doi:10.1016/j.jep.2015.05.041
   Web of Science ®Google Scholar
• Qian S, Huo D, Wang S, Qian Q. Inhibition of glucose-induced vascular endothelial growth factor expression by Salvia miltiorrhiza hydrophilic extract in human microvascular endothelial cells: evidence for mitochondrial oxidative stress. J Ethnopharmacol. 2011;137(2):985–991. doi:10.1016/j.jep.2011.07.018
   Web of Science ®Google Scholar
• Lu TC, Wu YH, Chen WY, Hung YC. Targeting oxidative stress and endothelial dysfunction using Tanshinone IIA for the treatment of tissue inflammation and fibrosis. Oxid Med Cell Longev. 2022;2022:2811789. doi:10.1155/2022/2811789
   Web of Science ®Google Scholar
• Ma S, Zhang D, Lou H, Sun L, Ji J. Evaluation of the anti-inflammatory activities of tanshinones isolated from Salvia miltiorrhiza var. alba roots in THP-1 macrophages. J Ethnopharmacol. 2016;188:193–199. doi:10.1016/j.jep.2016.05.018
   PubMed Web of Science ®Google Scholar
• Feng H, He Y, La L, et al. The flavonoid-enriched extract from the root of Smilax China L. inhibits inflammatory responses via the TLR-4-mediated signaling pathway. J Ethnopharmacol. 2020;256:112785. doi:10.1016/j.jep.2020.112785
   PubMed Web of Science ®Google Scholar
• Akhtar MS, Iqbal J. Evaluation of the hypoglycaemic effect of Achyranthes aspera in normal and alloxan-diabetic rabbits. J Ethnopharmacol. 1991;31(1):49–57. doi:10.1016/0378-8741(91)90143-2
   Web of Science ®Google Scholar
• Wang D, Li C, Fan W, Yi T, Wei A, Ma Y. Hypoglycemic and hypolipidemic effects of a polysaccharide from Fructus Corni in streptozotocin-induced diabetic rats. Int J Biol Macromol. 2019;133:420–427. doi:10.1016/j.ijbiomac.2019.04.160
   Web of Science ®Google Scholar
• Alharazi WZ, McGowen A, Rose P, Jethwa PH. Could consumption of yam (Dioscorea) or its extract be beneficial in controlling glycaemia: a systematic review. Br J Nutr. 2021;128(4):1–12.
   Web of Science ®Google Scholar
• Lau CH, Chan CM, Chan YW, et al. Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. Phytomedicine. 2007;14(11):778–784. doi:10.1016/j.phymed.2007.01.007
   Web of Science ®Google Scholar
• Torus B, Korkmaz H, Ozturk KH, et al. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy. Minerva Endocrinol. 2020. doi:10.23736/S0391-1977.20.03278-2
   PubMedGoogle Scholar
• Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2011;52(7):4402–4409. doi:10.1167/iovs.10-6879
   PubMed Web of Science ®Google Scholar
• Chen X, Zeng K, Xu M, et al. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death Dis. 2019;10(2):131. doi:10.1038/s41419-018-1188-3
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Chen L, et al. Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct Target Ther. 2021;6(1):409. doi:10.1038/s41392-021-00805-y
   PubMed Web of Science ®Google Scholar
• Massaro JD, Polli CD, Costa E Silva M, et al. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus. Mol Cell Endocrinol. 2019;490:1–14. doi:10.1016/j.mce.2019.03.008
   PubMed Web of Science ®Google Scholar
• Yan S, Wang T, Huang S, et al. Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes. Acta Diabetol. 2016;53(5):693–702. doi:10.1007/s00592-016-0837-1
   Web of Science ®Google Scholar
• Peipei N, Yanan G. Relationship between hsa-miR-1249 and hsa-miR-486-5p and type 2 diabetes mellitus. Acta Laser Biol. 2016;25(3):240–243.
   Google Scholar
• Wang G, Wu B, Zhang B, Wang K, Wang H. LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis. Biochem Biophys Res Commun. 2020;532(2):308–314. doi:10.1016/j.bbrc.2020.08.073
   PubMed Web of Science ®Google Scholar
• He J, Zhang R, Wang S, et al. Expression of microRNA-155-5p in patients with refractory diabetic macular edema and its regulatory mechanism. Exp Ther Med. 2021;22(3):975. doi:10.3892/etm.2021.10407
   Web of Science ®Google Scholar
• Huang Z, Mou T, Luo Y, et al. Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death Dis. 2020;11(6):455. doi:10.1038/s41419-020-2648-0
   PubMed Web of Science ®Google Scholar
• Gong X, Zhu L, Liu J, et al. MIR3142HG promotes lipopolysaccharide-induced acute lung injury by regulating miR-450b-5p/HMGB1 axis. Mol Cell Biochem. 2021;476(12):4205–4215. doi:10.1007/s11010-021-04209-y
   Web of Science ®Google Scholar
• Cao YL, Liu DJ, Zhang HG. MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation. Eur Rev Med Pharmacol Sci. 2018;22(14):4427–4430. doi:10.26355/eurrev_201807_15493
   PubMed Web of Science ®Google Scholar
• Ao H, Li H, Zhao X, Liu B, Lu L. TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy. Life Sci. 2021;267:118988. doi:10.1016/j.lfs.2020.118988
   PubMed Web of Science ®Google Scholar
• Zeng J, Zhao H, Chen B. DJ-1/PARK7 inhibits high glucose-induced oxidative stress to prevent retinal pericyte apoptosis via the PI3K/AKT/mTOR signaling pathway. Exp Eye Res. 2019;189:107830. doi:10.1016/j.exer.2019.107830
   Web of Science ®Google Scholar
• Qiu F, Tong H, Wang Y, Tao J, Wang H, Chen L. Recombinant human maspin inhibits high glucose-induced oxidative stress and angiogenesis of human retinal microvascular endothelial cells via PI3K/AKT pathway. Mol Cell Biochem. 2018;446(1–2):127–136. doi:10.1007/s11010-018-3280-5
   PubMed Web of Science ®Google Scholar
• Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50–83. doi:10.1128/MMBR.00031-10
   PubMed Web of Science ®Google Scholar
• Pearson G, Robinson F, Beers GT, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153–183. doi:10.1210/edrv.22.2.0428
   PubMed Web of Science ®Google Scholar
• Cervellini I, Galino J, Zhu N, Allen S, Birchmeier C, Bennett DL. Sustained MAPK/ERK activation in adult Schwann cells impairs nerve repair. J Neurosci. 2018;38(3):679–690. doi:10.1523/JNEUROSCI.2255-17.2017
   Web of Science ®Google Scholar
• El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006;168(1):235–244. doi:10.2353/ajpath.2006.050500
   PubMed Web of Science ®Google Scholar